Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients

BACKGROUND: Kidney transplantation is the preferred form of kidney replacement therapy for patients with end‐stage kidney disease (ESKD) and is often complicated by worsening or new‐onset diabetes. Management of hyperglycaemia is important to reduce post‐transplant and diabetes‐related complications...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cochrane Database Syst Rev
Main Authors: Lo, Clement, Jun, Min, Badve, Sunil V, Pilmore, Helen, White, Sarah L, Hawley, Carmel, Cass, Alan, Perkovic, Vlado, Zoungas, Sophia
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2017
Teme:
Medicine General & Introductory Medical Sciences
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464265/
https://ncbi.nlm.nih.gov/pubmed/28238223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009966.pub2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki